The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial
溶瘤腺病毒 TILT-123 与派姆单抗联合治疗铂类耐药或难治性卵巢癌：1a 期 PROTA 试验
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-025-56482-w
Matthew Stephen Block #, James Hugo Armstrong Clubb #, Johanna Mäenpää, Santeri Pakola, Dafne Carolina Alves Quixabeira, Tatiana Kudling, Elise Jirovec, Lyna Haybout, Mirte van der Heijden, Sanae Zahraoui, Susanna Grönberg-Vähä-Koskela, Sini Raatikainen, Victor Arias, Saru Basnet, Nea Ojala, Teijo P
